Changes to the Pharmaceutical Benefits Schedule in 2016 have made it possible for GPs to prescribe treatment to patients with hepatitis C. With nearly 90% of these patients yet to receive their treatment, your clinic can really make a difference! Testing and treating patients is simple: new treatments result in virtually no side effects and […]
On 6 June 2017 the Cochrane Collaboration published a review of all the randomised controlled trials conducted by the manufacturers of hepatitis C medicines in order to get their drugs licensed. In short Cochrane finds that the drugs may clear the virus from the blood, but there is no evidence that they prevent harm from […]
Hepatitis ACT has learned of recent concerns about a small number of cases nationally of hepatitis A apparently linked to a batch of frozen berries. At the time of writing there has been three cases reported (one in each of Victoria, Queensland and South Australia). Entyce Food Ingredients has recalled their 300g ‘Creative Gourmet Mix […]
This notice is prompted by conversations with community hepatitis organisations, specialists, doctors and health consumers. This advice comes with the strong endorsement of Associate Professor Simone Strasser, Senior Staff Specialist at the AW Morrow Gastroenterology and Liver Centre at the Royal Prince Alfred Hospital in Sydney. It is absolutely essential for anyone and everyone undergoing […]